News

REGENXBIO's Upcoming Presentation at World Muscle Society Event

REGENXBIO's Upcoming Presentation at World Muscle Society Event

REGENXBIO's Participation in International Congress

REGENXBIO Inc. (Nasdaq: RGNX) is excited to announce that its Chief Medical Officer, Steve Pakola, M.D., will be presenting at the International Congress of the World Muscle Society. This significant event will take place in Vienna, Austria, from October 7 to October 11.

Insights on RGX-202 and Its Clinical Data

The upcoming podium presentation will focus on new analyses derived from previous 12-month functional data related to the Phase I/II trial of RGX-202. This session will specifically highlight patient improvements on the North Star Ambulatory Assessment (NSAA), utilizing the established cTAP disease progression model from the Collaborative Trajectory Analysis Project. Notably, RGX-202 maintained a favorable safety profile, with no serious adverse events or concerns raised during the study.

Performance Compared to Control Groups

RGX-202's participants outperformed baseline-matched external natural history controls across all functional measures, further validating the therapy’s potential. This reinforces RGX-202’s positioning as a standout candidate in the therapeutic space for Duchenne muscular dystrophy.

Details of the Presentation

This engaging presentation is titled "RGX-202: An Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy: Interim Clinical Data." Dr. Steve Pakola, who serves as REGENXBIO's Chief Medical Officer, will lead the session during Short Oral Presentations 1, focused on updates from SMA and DMD trials.

The talk is scheduled for October 8 at 3:30 PM CET, accompanied by a poster presentation (P425) for additional insights.

Exploring RGX-202's Innovative Approach

RGX-202 is characterized as a groundbreaking investigational gene therapy aimed at improving functional outcomes in patients with Duchenne muscular dystrophy. What sets RGX-202 apart is its differentiated microdystrophin construct, which effectively encodes critical regions of natural dystrophin, including the C-Terminal (CT) domain.

Designed with unique features such as codon optimization, RGX-202 strives to enhance gene expression, boost protein translation efficiency, and minimize immunogenic responses. This gene therapy is adept at supporting targeted microdystrophin expression across both skeletal and cardiac muscle, facilitated by the NAV AAV8 vector combined with a specialized muscle-specific promoter (Spc5-12). REGENXBIO manufactures RGX-202 utilizing its proprietary, high-yield NAVXpress suspension-based platform.

About REGENXBIO and Its Mission

Founded in 2009, REGENXBIO is at the forefront of biotechnology, dedicated to transforming healthcare through the promising field of gene therapy. The company's mission is to enhance lives by harnessing the curative potential found in their innovative gene therapies. Their late-stage pipeline includes groundbreaking treatments for rare and retinal diseases, with RGX-202 specifically targeting Duchenne muscular dystrophy, alongside other therapies developed under partnerships with Nippon Shinyaku and AbbVie.

REGENXBIO’s AAV platform has successfully treated thousands of patients, showcasing the transformative potential these therapies can offer in reshaping health outcomes. As they continue to push boundaries, the vision for REGENXBIO remains focused on changing healthcare dynamics for countless individuals.

Frequently Asked Questions

What is RGX-202?

RGX-202 is an investigational gene therapy designed to improve outcomes for patients with Duchenne muscular dystrophy.

When will the presentation take place?

The presentation will occur on October 8 at 3:30 PM CET at the World Muscle Society Congress.

Who will present the clinical data on RGX-202?

Dr. Steve Pakola, the Chief Medical Officer of REGENXBIO, will lead the presentation.

What makes RGX-202 stand out in its category?

RGX-202 features a unique microdystrophin construct aimed at enhancing protein function, setting it apart from other therapies.

Where can I find more information about REGENXBIO?

More details about REGENXBIO and its therapies can be found on their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Energy Fuels Secures Key Financing for Donald Project

Updated Category News Views 113

Donald Project: A Step Closer to Reality Look, when those rare earths start moving, the entire market gets a whiff of promise. Energy Fuels' Donald Rare Earth and Mineral Sands Project in Australia is gearing up for real action with a fresh funding nod. Export Finance Australia and the National Reconstruction Fund Corporation have conditionally greenlit up to A$180...

Continue Reading
Posterity Health Boosts Network to Six New Markets

Updated Category News Views 0

Expansion at Breakneck Speed Just like that, we've got Posterity Health making power moves across the country, staking claim in six major markets. Denver's very own fertility platform is on a roll, and this ain't just any rollout. We're talking partnerships like confetti in the air, dotting spots from the sunny Cali shores of Orange County to the bustling streets of...

Continue Reading
Custom Concrete: Crafting the Perfect Poolside Paradise

Updated Category News Views 99

Concrete: The Unsung Hero of Your Pool's Success You know, everyone always raves about that sparkling pool, but let's be real—it's the concrete holding the whole gig together. James White from White's Pools in Loganville, GA, drops some knowledge in a recent HelloNation piece about the unsung hero of backyard oases: custom concrete. Yeah, it's not sexy, but when you're...

Continue Reading
Cassava Bolsters African AI Access Via Anthropic's Claude

Updated Category News Views 25

Africa's Tech Scene Gets a Boost with Cassava's Latest Move The tech world often feels like a whirlwind, and today, Cassava Technologies is throwing its hat into the ring as an authorised reseller for Claude on Amazon Bedrock. That's Anthropic’s big kahuna of a language model, in case you're wondering. With this setup, Cassava is opening doors for businesses across...

Continue Reading
CPSC's Management Overhaul: Progress or Just Polishing?

Updated Category News Views 176

The Tangled Web of Bureaucracy Ah, the Consumer Product Safety Commission—CPSC for short. It's like the Secretariat of product safety, but often knee-deep in old problems. Over the years, hearing about their challenges is like flipping through a well-worn playbook. But now, the talk is all about a fresh page under Acting Chairman Peter A. Feldman. The watchdog in...

Continue Reading
OperaWine 2027 Spotlights Women-Led Italian Wineries

Updated Category News Views 122

The Rise of Women's Leadership in Italian Winemaking If there’s anything that gets me up off the bench, it’s innovation in tradition. And that's just what Vinitaly OperaWine is doing in 2027. For the first time, they've carved out a special category, "Led by Women," featuring a lineup of 46 Italian wineries ran by women. These ladies are stepping into the limelight at...

Continue Reading
Philips’ Beauty Tech Trends Promise Intimacy by 2027

Updated Category News Views 66

Beauty Tech Takes a Personal Turn It's 2026, and in the beauty industry, folks are trading flashy for the intimate and intelligent. Philips, that stalwart of tech innovation, is waving the banner, revealing three beauty trends we can't ignore if we plan to keep up with the times. The Rise of Intelligent Guidance First off, everyone and their dog seems to ask how tech is...

Continue Reading
Beer B Que Music Festival: Hip-Hop, Dancehall & Brews

Updated Category News Views 0

A Melody and Brew-Infused South Florida Celebration Boy, if festivals were stocks, I'd have bought into the Beer B Que Music Festival years ago. This event, rolling into its seventh year, isn't just another line-up of artists—it feels like a genuine cultural reunion for folks in South Florida. You throw in some heavyweight names like Rick Ross and Kodak Black, plus the...

Continue Reading
Counterfeits in Aerospace: Industry Tackles Supply Risks

Updated Category News Views 68

The Trouble with Counterfeit Parts in Aerospace Ah, aerospace—the domain where milliseconds matter, and materials must be tougher than a New York steelworker's boots. But guess what's throwing a wrench in the works? Counterfeit parts. That's right, the sector's latest buzzkill is as sneaky as a penny stock scam, and it's about time the industry's heavyweights had a...

Continue Reading
Dudley DeBosier Lends a Hand with Thanksgiving Giveaway

Updated Category News Views 117

Small Gestures Making a Big Difference Ah, Thanksgiving—a time of turkey, stuffing, and cranberries, with grocery receipts long enough to make your eyes water. And wouldn't you know, Dudley DeBosier Injury Lawyers is stepping in with a little relief, dishing out $2,000 in gift cards. This Louisiana-based law firm is giving away ten $200 gift cards to residents just in...

Continue Reading

Top 5 Most Recently Viewed Articles

On Holding AG: Analyst Insights and Long-Term Outlook

Updated Category News Views 396

Exploring On Holding AG's Current Challenges On Holding AG (NYSE: ONON) is making headlines as its stock experiences a recovery following a downgrade from Raymond James this week. Although shares initially dropped around 2.5% recently, there are many factors at play surrounding its market performance. Recent Analyst Downgrade Insights As of late, Raymond James analyst...

Continue Reading
DreamHost Expands Global Reach With Data Center in Amsterdam

Updated Category News Views 114

DreamHost Expands Global Data Center Network DreamHost, a prominent player in providing web hosting and Managed WordPress services, has recently made a significant stride by opening its first international data center in Amsterdam. This strategic expansion is designed to enhance service delivery for customers located outside the United States. Improved Performance and...

Continue Reading
Key Events and Insights from Week 34 of the Trump Era

Updated Category News Views 214

Reflections on Week 34 of the Trump Administration As we delve into Week 34 of the Trump Administration, it's evident that this period was marked by significant events and a showcase of resilience. The week began with reflections on a tragic day, as Americans remembered the impact of past events. The strength of the nation shone through in the face of adversity....

Continue Reading
Exploring the Future of OSAT Services Market Growth Trends

Updated Category News Views 120

Market Overview of Outsourced Semiconductor Assembly and Test Services The Outsourced Semiconductor Assembly and Test (OSAT) services market is experiencing a remarkable transformation, primarily attributed to the increasing complexity of semiconductor devices and a substantial demand for cost-effective manufacturing solutions. As per recent market insights, this sector,...

Continue Reading
SHOPLINE and LvLUp Ventures Set to Revolutionize 50 Brands

Updated Category News Views 342

SHOPLINE and LvLUp Ventures on a Transformative Journey SHOPLINE, a revered global commerce platform utilized by over 600,000 merchants, is deepening its collaboration with LvLUp Ventures, focusing on emerging consumer brands. This partnership aims to revolutionize over 50 brands in the CPG and lifestyle sectors by the end of the year. They have catalyzed the rapid growth...

Continue Reading